Todd M. Brown
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Todd M. Brown has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Vera Bittner
Division of Cardiovascular Disease, University of Alabama at Birmingham , Birmingham, AL
11 shared publications - Monika M. Safford
Weill Cornell Medicine, New York, NY
7 shared publications Monika M. Safford
School of Medicine, University of Alabama at Birmingham, Birmingham, AL
6 shared publications- Lisandro Damian Colantonio
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL
5 shared publications Paul Muntner
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA
5 shared publications- Emily B. Levitan
Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA
4 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
- Vol. 19 (9) , e013136
Neighborhood Social Determinants of Health and Referral to Cardiac Rehabilitation: An Analysis of the Get With The Guidelines–Coronary Artery Disease Registry
BACKGROUND: Despite strong guideline recommendations for cardiac rehabilitation (CR) following an acute myocardial infarction, CR referral is suboptimal, with disparities by sex, race, ethnicity, insurance, and geographic area. The influence of social determinants of health on CR referral has not been well studied. METHODS: We analyzed cross-sectional data from the Get With The Guidelines–Coronary Artery Disease registry on patients discharged alive following an ST-segment–elevation myocardial infarction from 2020 to 2022. We used generalized estimating equations to analyze the association between neighborhood social determinants of health (using ZIP codes) and CR referral at discharge, controlling for patient- and hospital-level characteristics. We examined quintiles of the neighborhood Social Deprivation Index and the following social determinants of health domains: socioeconomic status (income, education, employment), culture (nativity and English proficiency), access to care, residential environment, and social support. RESULTS: Among 79 694 patients hospitalized for acute myocardial infarction, the median age was 62 years, 28% were women, 72% were non-Hispanic White, and 82.6% were referred to CR at discharge. Patients residing in the most deprived Social Deprivation Index quintile had lower odds of being referred to CR than those in the least deprived quintile (adjusted odds ratio [aOR], 0.78 [95% CI, 0.64–0.96]). Patients had lower odds of being referred to CR if they resided in a neighborhood with high proportions of residents lacking a high school degree (aOR, 0.46 [95% CI, 0.31–0.68]), unemployed residents (aOR, 0.73 [95% CI, 0.58–0.91]), foreign-born residents (aOR, 0.63 [95% CI, 0.46–0.86]), residents with limited English proficiency (aOR, 0.51 [95% CI, 0.34–0.78]), and households without a vehicle (aOR, 0.74 [95% CI, 0.58–0.95]). CONCLUSIONS: CR referral was lowest among patients living in the most deprived neighborhoods. Efforts are needed to equitably improve low CR referral rates among individuals living in the most deprived neighborhoods.
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
- Vol. 19 (9) , e013136
Open AccessNeighborhood Social Determinants of Health and Referral to Cardiac Rehabilitation: An Analysis of the Get With The Guidelines–Coronary Artery Disease Registry
BACKGROUND: Despite strong guideline recommendations for cardiac rehabilitation (CR) following an acute myocardial infarction, CR referral is suboptimal, with disparities by sex, race, ethnicity, insurance, and geographic area. The influence of social determinants of health on CR referral has not been well studied. METHODS: We analyzed cross-sectional data from the Get With The Guidelines–Coronary Artery Disease registry on patients discharged alive following an ST-segment–elevation myocardial infarction from 2020 to 2022. We used generalized estimating equations to analyze the association between neighborhood social determinants of health (using ZIP codes) and CR referral at discharge, controlling for patient- and hospital-level characteristics. We examined quintiles of the neighborhood Social Deprivation Index and the following social determinants of health domains: socioeconomic status (income, education, employment), culture (nativity and English proficiency), access to care, residential environment, and social support. RESULTS: Among 79 694 patients hospitalized for acute myocardial infarction, the median age was 62 years, 28% were women, 72% were non-Hispanic White, and 82.6% were referred to CR at discharge. Patients residing in the most deprived Social Deprivation Index quintile had lower odds of being referred to CR than those in the least deprived quintile (adjusted odds ratio [aOR], 0.78 [95% CI, 0.64–0.96]). Patients had lower odds of being referred to CR if they resided in a neighborhood with high proportions of residents lacking a high school degree (aOR, 0.46 [95% CI, 0.31–0.68]), unemployed residents (aOR, 0.73 [95% CI, 0.58–0.91]), foreign-born residents (aOR, 0.63 [95% CI, 0.46–0.86]), residents with limited English proficiency (aOR, 0.51 [95% CI, 0.34–0.78]), and households without a vehicle (aOR, 0.74 [95% CI, 0.58–0.95]). CONCLUSIONS: CR referral was lowest among patients living in the most deprived neighborhoods. Efforts are needed to equitably improve low CR referral rates among individuals living in the most deprived neighborhoods.
- 22 August 2024
- Published by Elsevier in American Heart Journal
- Vol. 279, 118-120
Cholesterol lowering therapy is highly efficacious in reducing atherosclerotic cardiovascular disease risk but grossly underutilized: How do we move the needle?
- 22 August 2024
- Published by Elsevier in American Heart Journal
- Vol. 279, 118-120
Cholesterol lowering therapy is highly efficacious in reducing atherosclerotic cardiovascular disease risk but grossly underutilized: How do we move the needle?
- Open Access
- 7 June 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (11) , e025397
Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease
Background: It is unclear whether lipoprotein(a) is associated with coronary heart disease (CHD) and ischemic stroke events in White and Black adults with atherosclerotic cardiovascular disease (ASCVD). Methods and Results: We conducted a case‐cohort analysis, including Black and White REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants ≥45 years of age with prevalent ASCVD (ie, CHD or stroke) at baseline between 2003 and 2007. Baseline lipoprotein(a) molar concentration was measured in participants with ASCVD who experienced a CHD event by December 2017 (n=1166) or an ischemic stroke by September 2019 (n=492) and in a random subcohort of participants with prevalent ASCVD (n=1948). The hazard ratio (HR) for CHD events per 1 SD (1.5 units) higher log‐transformed lipoprotein(a) was 1.26 (95% CI, 1.02–1.56) among Black participants and 1.16 (95% CI, 1.02–1.31) among White participants ( P value comparing HRs, 0.485). The HR for CHD events per 1 SD higher log‐lipoprotein(a) within subgroups with hs‐CRP (high‐sensitivity C‐reactive protein) ≥2 and P value comparing HRs, 0.836), among Black participants, and 1.07 (95% CI, 0.91–1.27) and 1.36 (95% CI, 1.10–1.70), respectively ( P value comparing HRs, 0.088), among White participants. There was no evidence that the association between lipoprotein(a) and CHD events differed by statin use. There was no evidence of an association between lipoprotein(a) and ischemic stroke events among Black or White participants. Conclusions: Higher lipoprotein(a) levels were associated with an increased risk for CHD events in Black and White adults with ASCVD.
- 7 June 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (11) , e025397
Open AccessLipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease
Background: It is unclear whether lipoprotein(a) is associated with coronary heart disease (CHD) and ischemic stroke events in White and Black adults with atherosclerotic cardiovascular disease (ASCVD). Methods and Results: We conducted a case‐cohort analysis, including Black and White REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants ≥45 years of age with prevalent ASCVD (ie, CHD or stroke) at baseline between 2003 and 2007. Baseline lipoprotein(a) molar concentration was measured in participants with ASCVD who experienced a CHD event by December 2017 (n=1166) or an ischemic stroke by September 2019 (n=492) and in a random subcohort of participants with prevalent ASCVD (n=1948). The hazard ratio (HR) for CHD events per 1 SD (1.5 units) higher log‐transformed lipoprotein(a) was 1.26 (95% CI, 1.02–1.56) among Black participants and 1.16 (95% CI, 1.02–1.31) among White participants ( P value comparing HRs, 0.485). The HR for CHD events per 1 SD higher log‐lipoprotein(a) within subgroups with hs‐CRP (high‐sensitivity C‐reactive protein) ≥2 and P value comparing HRs, 0.836), among Black participants, and 1.07 (95% CI, 0.91–1.27) and 1.36 (95% CI, 1.10–1.70), respectively ( P value comparing HRs, 0.088), among White participants. There was no evidence that the association between lipoprotein(a) and CHD events differed by statin use. There was no evidence of an association between lipoprotein(a) and ischemic stroke events among Black or White participants. Conclusions: Higher lipoprotein(a) levels were associated with an increased risk for CHD events in Black and White adults with ASCVD.
- 16 November 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (Suppl_1)
Abstract 9121: Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults with Cardiovascular Disease
- 16 November 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (Suppl_1)
Abstract 9121: Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults with Cardiovascular Disease
- Open Access
- 6 July 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (13) , e019158
Mediterranean Diet Score, Dietary Patterns, and Risk of Sudden Cardiac Death in the REGARDS Study
Background: Sudden cardiac death (SCD) is a common cause of death in the United States. Few previous studies have investigated the associations of diet scores and dietary patterns with risk of SCD. We investigated the associations of the Mediterranean diet score and various dietary patterns with risk of SCD in participants in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study cohort. Methods and Results: Diet was assessed with a food frequency questionnaire administered at baseline in REGARDS. The Mediterranean diet score was derived based on the consumption of specific food groups considered beneficial or detrimental components of that diet. Dietary patterns were derived previously using factor analysis, and adherence to each pattern was scored. SCD events were ascertained through regular contacts. Cox proportional hazards regression was used to examine the risk of SCD events associated with the Mediterranean diet score and adherence to each of the 5 dietary patterns overall and stratifying on history of coronary heart disease at baseline. The analytic sample included 21 069 participants with a mean 9.8±3.8 years of follow‐up. The Mediterranean diet score showed a trend toward an inverse association with risk of SCD after multivariable adjustment (hazard ratio [HR] comparing highest with lowest group, 0.74; 95% CI, 0.55–1.01; P trend =0.07). There was a trend toward a positive association of the Southern dietary pattern with risk of SCD (HR comparing highest with lowest quartile of adherence, 1.46; 95% CI, 1.02–2.10; P trend =0.06). Conclusions: In REGARDS participants, we identified trends toward an inverse association of the Mediterranean diet score and a positive association of adherence to the Southern dietary pattern with risk of SCD.
- 6 July 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (13) , e019158
Open AccessMediterranean Diet Score, Dietary Patterns, and Risk of Sudden Cardiac Death in the REGARDS Study
Background: Sudden cardiac death (SCD) is a common cause of death in the United States. Few previous studies have investigated the associations of diet scores and dietary patterns with risk of SCD. We investigated the associations of the Mediterranean diet score and various dietary patterns with risk of SCD in participants in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study cohort. Methods and Results: Diet was assessed with a food frequency questionnaire administered at baseline in REGARDS. The Mediterranean diet score was derived based on the consumption of specific food groups considered beneficial or detrimental components of that diet. Dietary patterns were derived previously using factor analysis, and adherence to each pattern was scored. SCD events were ascertained through regular contacts. Cox proportional hazards regression was used to examine the risk of SCD events associated with the Mediterranean diet score and adherence to each of the 5 dietary patterns overall and stratifying on history of coronary heart disease at baseline. The analytic sample included 21 069 participants with a mean 9.8±3.8 years of follow‐up. The Mediterranean diet score showed a trend toward an inverse association with risk of SCD after multivariable adjustment (hazard ratio [HR] comparing highest with lowest group, 0.74; 95% CI, 0.55–1.01; P trend =0.07). There was a trend toward a positive association of the Southern dietary pattern with risk of SCD (HR comparing highest with lowest quartile of adherence, 1.46; 95% CI, 1.02–2.10; P trend =0.06). Conclusions: In REGARDS participants, we identified trends toward an inverse association of the Mediterranean diet score and a positive association of adherence to the Southern dietary pattern with risk of SCD.
- Open Access
Risk for cardiovascular events following ‘microsize’ versus usual myocardial infarctions
Background Microsize myocardial infarction (MI) is a recently described phenomenon that meets rigorous criteria for MI with very low peak troponin elevations. We aim to compare the risk for cardiovascular events and mortality following microsize versus usual MIs. Methods and results Prospective cohort analysis of REasons for Geographic And Racial Differences in Stroke (REGARDS) study participants without a history of coronary heart disease (CHD) who had an incident MI between 2003 and 2015. Incident MIs were classified as microsize MI (peak troponin Conclusion Microsize MIs have a prognostic value for future cardiovascular events and mortality comparable to usual MIs. These findings should encourage clinicians to initiate secondary prevention strategies in patients with microsize MI until this emerging clinical entity is better understood.
Open AccessRisk for cardiovascular events following ‘microsize’ versus usual myocardial infarctions
Background Microsize myocardial infarction (MI) is a recently described phenomenon that meets rigorous criteria for MI with very low peak troponin elevations. We aim to compare the risk for cardiovascular events and mortality following microsize versus usual MIs. Methods and results Prospective cohort analysis of REasons for Geographic And Racial Differences in Stroke (REGARDS) study participants without a history of coronary heart disease (CHD) who had an incident MI between 2003 and 2015. Incident MIs were classified as microsize MI (peak troponin Conclusion Microsize MIs have a prognostic value for future cardiovascular events and mortality comparable to usual MIs. These findings should encourage clinicians to initiate secondary prevention strategies in patients with microsize MI until this emerging clinical entity is better understood.
- 1 March 2020
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 14 (2) , 260-270
Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction
- 1 March 2020
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 14 (2) , 260-270
Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction
- 1 October 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (Supplement)
P652Lower use of statins among patients with peripheral artery disease compared with those with coronary heart disease
Background: Adults with atherosclerotic cardiovascular disease are recommended to take a statin to reduce their risk for future cardiovascular events. Prior studies suggest that statins are being taken by most adults with coronary heart disease (CHD). However, there are few data on the use of statins among adults with peripheral artery disease (PAD). Purpose: To compare the use of statins among US adults with a history of PAD versus those with a history of CHD. Methods: We conducted a retrospective cohort study among US adults ≥19 years of age with commercial or government health insurance who had a history of CHD or PAD as of December 31, 2014 (n=1,006,451, mean age 63 years, 47% male). We used pharmacy claims between January 1 and December 31, 2014 to identify use of any statin and of a high-intensity statin (i.e., atorvastatin 40–80 mg, rosuvastatin 20–40 mg, simvastatin 80 mg). Patients with a history of CHD without PAD (CHD only), both CHD and PAD, and PAD without CHD (PAD only) were analysed. Prevalence ratios for use of any statin and a high-intensity statin among those taking a statin were calculated after multivariable adjustment for sociodemographics and cardiovascular risk factors. Results: Overall, 69.1% of patients included in the current analysis had CHD only, 21.4% had both CHD and PAD, and 9.5% had PAD only. Overall, 66.0%, 68.2% and 47.5% of patients with CHD only, CHD and PAD, and PAD only were taking a statin. After multivariable adjustment and compared to patients with CHD only, the prevalence ratio for statin use was 1.02 (95% CI 1.01, 1.02) for those with both CHD and PAD and 0.82 (95% CI 0.82, 0.83) for those with PAD only. Among patients taking a statin, 29.4% of those with CHD only, 28.6% of those with both CHD and PAD, and 17.3% of those with PAD only were taking a high-intensity dosage. Compared to patients with CHD only, the multivariable adjusted prevalence ratio for taking a high-intensity dosage was 1.05 (95% CI 1.04, 1.06) for those with both CHD and PAD and 0.71 (95% CI 0.70, 0.73) for those with PAD only. Conclusion: Adults with PAD receive less intensive statin therapy compared with their counterparts who have CHD. Interventions aimed to increase statin use among patients with PAD are warranted. Acknowledgement/Funding: This study was supported through a research grant from Amgen, Inc. (Thousand Oaks, CA, USA).
- 1 October 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (Supplement)
P652Lower use of statins among patients with peripheral artery disease compared with those with coronary heart disease
Background: Adults with atherosclerotic cardiovascular disease are recommended to take a statin to reduce their risk for future cardiovascular events. Prior studies suggest that statins are being taken by most adults with coronary heart disease (CHD). However, there are few data on the use of statins among adults with peripheral artery disease (PAD). Purpose: To compare the use of statins among US adults with a history of PAD versus those with a history of CHD. Methods: We conducted a retrospective cohort study among US adults ≥19 years of age with commercial or government health insurance who had a history of CHD or PAD as of December 31, 2014 (n=1,006,451, mean age 63 years, 47% male). We used pharmacy claims between January 1 and December 31, 2014 to identify use of any statin and of a high-intensity statin (i.e., atorvastatin 40–80 mg, rosuvastatin 20–40 mg, simvastatin 80 mg). Patients with a history of CHD without PAD (CHD only), both CHD and PAD, and PAD without CHD (PAD only) were analysed. Prevalence ratios for use of any statin and a high-intensity statin among those taking a statin were calculated after multivariable adjustment for sociodemographics and cardiovascular risk factors. Results: Overall, 69.1% of patients included in the current analysis had CHD only, 21.4% had both CHD and PAD, and 9.5% had PAD only. Overall, 66.0%, 68.2% and 47.5% of patients with CHD only, CHD and PAD, and PAD only were taking a statin. After multivariable adjustment and compared to patients with CHD only, the prevalence ratio for statin use was 1.02 (95% CI 1.01, 1.02) for those with both CHD and PAD and 0.82 (95% CI 0.82, 0.83) for those with PAD only. Among patients taking a statin, 29.4% of those with CHD only, 28.6% of those with both CHD and PAD, and 17.3% of those with PAD only were taking a high-intensity dosage. Compared to patients with CHD only, the multivariable adjusted prevalence ratio for taking a high-intensity dosage was 1.05 (95% CI 1.04, 1.06) for those with both CHD and PAD and 0.71 (95% CI 0.70, 0.73) for those with PAD only. Conclusion: Adults with PAD receive less intensive statin therapy compared with their counterparts who have CHD. Interventions aimed to increase statin use among patients with PAD are warranted. Acknowledgement/Funding: This study was supported through a research grant from Amgen, Inc. (Thousand Oaks, CA, USA).
- Open Access
- 7 March 2019
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
- Vol. 5 (4) , 343-351
Risk factors for ‘microsize’ vs. usual myocardial infarctions in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study
Aims: A recently described phenomenon is that of myocardial infarction (MI) events that meet criteria for MI, but that have very low peak troponin elevations, so-called ‘microsize MI’. These events are very common and associated with increased risk of all-cause mortality. Our aim is to compare risk factors for microsize MI vs. usual MI events. Methods and results: Among 24 470 participants of the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort free of coronary heart disease at baseline, heart-related hospitalizations were expert adjudicated for MI using published guidelines. Myocardial infarctions were classified as microsize MI (peak troponin <0.5 ng/mL) or usual MI (peak troponin ≥0.5 ng/mL). Competing risk analyses assessed associations between baseline risk factors and incident microsize vs. usual MI. Between 2003 and 2013 there were 891 MIs; 279 were microsize MI and 612 were usual MI. Risk factors for both usual MI and microsize MI include age, gender, diabetes, and urinary albumin to creatinine ratio. Risk factors for only usual MI include Residence in the Stroke Belt and Buckle regions and current smoking. Black race was associated with a uniquely lower risk of usual MI. Conclusion: The similarities in risk profiles suggest a possible common aetiology and should encourage clinicians to both treat reversible risk factors for microsize MI and to initiate secondary prevention strategies following these events until this emerging clinical entity is better understood. Future studies should further assess the clinical outcomes of these two entities and their effect on future management.
- 7 March 2019
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
- Vol. 5 (4) , 343-351
Open AccessRisk factors for ‘microsize’ vs. usual myocardial infarctions in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study
Aims: A recently described phenomenon is that of myocardial infarction (MI) events that meet criteria for MI, but that have very low peak troponin elevations, so-called ‘microsize MI’. These events are very common and associated with increased risk of all-cause mortality. Our aim is to compare risk factors for microsize MI vs. usual MI events. Methods and results: Among 24 470 participants of the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort free of coronary heart disease at baseline, heart-related hospitalizations were expert adjudicated for MI using published guidelines. Myocardial infarctions were classified as microsize MI (peak troponin <0.5 ng/mL) or usual MI (peak troponin ≥0.5 ng/mL). Competing risk analyses assessed associations between baseline risk factors and incident microsize vs. usual MI. Between 2003 and 2013 there were 891 MIs; 279 were microsize MI and 612 were usual MI. Risk factors for both usual MI and microsize MI include age, gender, diabetes, and urinary albumin to creatinine ratio. Risk factors for only usual MI include Residence in the Stroke Belt and Buckle regions and current smoking. Black race was associated with a uniquely lower risk of usual MI. Conclusion: The similarities in risk profiles suggest a possible common aetiology and should encourage clinicians to both treat reversible risk factors for microsize MI and to initiate secondary prevention strategies following these events until this emerging clinical entity is better understood. Future studies should further assess the clinical outcomes of these two entities and their effect on future management.